EMvision Medical Devices Ltd. ASX: EMV Share Price & Review

EMV Overview

EMV Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About EMV

Website

EMvision Medical Devices Ltd.

Telephone

61.2.8667.5337

Address

Suite 4.01 65 Epping Road Macquarie Park, New South Wales (NSW) 2113

Description

EMvision Medical Devices Ltd. engages in the development & commercialization of medical imaging technology. The company was founded on July 11, 2017, and is headquartered in Brisbane, Australia.

EMV Price Chart

Key Stats

Market Cap

AU$153.93M

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.63 - 2.35

Trade Value (12mth)

AU$15,551.00

1 week

2.86%

1 month

3.75%

YTD

-4.26%

1 year

-13.46%

All time high

4.20

Key Fundamentals

EPS 3 yr Growth

-71.70%

EBITDA Margin

N/A

Operating Cashflow

-$6m

Free Cash Flow Return

-46.50%

ROIC

-21.20%

Interest Coverage

-112.90

Quick Ratio

6.40

Other Data

Shares on Issue (Fully Dilluted)

85m

HALO Sector

Healthcare

Next Company Report Date

02-Sep-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

EMV Announcements

Latest Announcements

Date	Announcements
15 August 25	EMVision Awarded $3m Grant For Regional Benefits Study × EMVision Awarded $3m Grant For Regional Benefits Study
11 August 25	Notification regarding unquoted securities - EMV × Notification regarding unquoted securities - EMV
30 July 25	Quarterly Activities/Appendix 4C Cash Flow Report × Quarterly Activities/Appendix 4C Cash Flow Report
29 July 25	First Responder Program Advanced & Grant Milestone Achieved × First Responder Program Advanced & Grant Milestone Achieved
02 July 25	Key Developments in Pivotal Trial & Innovation Study × Key Developments in Pivotal Trial & Innovation Study
16 June 25	EMVision Awarded $5m Non-Dilutive Government Grant × EMVision Awarded $5m Non-Dilutive Government Grant
05 June 25	Initial Director's Interest Notice × Initial Director's Interest Notice
05 June 25	Non-Executive Director Appointment × Non-Executive Director Appointment
03 June 25	Additional Pivotal Trial Site Activations × Additional Pivotal Trial Site Activations
21 May 25	Enhanced Algorithm Performance From Continuous Innovation × Enhanced Algorithm Performance From Continuous Innovation
30 April 25	Quarterly Activities/Appendix 4C Cash Flow Report × Quarterly Activities/Appendix 4C Cash Flow Report
28 April 25	Activation of Second US Pivotal Trial Site, Mayo Clinic × Activation of Second US Pivotal Trial Site, Mayo Clinic
16 April 25	Non-Executive Director Retirement × Non-Executive Director Retirement
16 April 25	Final Director's Interest Notice × Final Director's Interest Notice
27 March 25	Emu Pivotal Validation Trial Commences × Emu Pivotal Validation Trial Commences
21 March 25	Change of Share Registry Details × Change of Share Registry Details
19 March 25	First Responder Scanner in Successful Aeromedical Testing × First Responder Scanner in Successful Aeromedical Testing
07 March 25	S&P DJI Announces March 2025 Quarterly Rebalance × S&P DJI Announces March 2025 Quarterly Rebalance
27 February 25	Half Yearly Report and Accounts × Half Yearly Report and Accounts
27 February 25	EMVision Releases its FY25 Half Yearly Report × EMVision Releases its FY25 Half Yearly Report
12 February 25	US Ethics Approval Received for Pivotal Validation Trial × US Ethics Approval Received for Pivotal Validation Trial
28 January 25	Quarterly Activities/Appendix 4C Cash Flow Report × Quarterly Activities/Appendix 4C Cash Flow Report
20 January 25	EMVision Receives $2.12m R&D Tax Rebate × EMVision Receives $2.12m R&D Tax Rebate
02 December 24	Notification of cessation of securities - EMV × Notification of cessation of securities - EMV
28 November 24	Presentation - Ord Minnett Biotech & Medtech Conference × Presentation - Ord Minnett Biotech & Medtech Conference

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

%

DPSg

N/A

Quality Yield

Falling Divs over next 2

Values and Recommendations

Key Stats

Consensus Score

Recommendation

EPS 1 month Change

Quality Yield

Falling Divs over next 2

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

EMV Shortsell

Frequently Asked Questions

What is the current share price of EMvision Medical Devices Ltd. (EMV:ASX)?

The current share price of EMvision Medical Devices Ltd. (EMV:ASX) is AU$1.84.

What is the 52-week high share price for EMvision Medical Devices Ltd. (EMV:ASX)?

The 52-week high share price for EMvision Medical Devices Ltd. (EMV:ASX) is AU$2.35.

What is the 52-week low share price for EMvision Medical Devices Ltd. (EMV:ASX)?

The 52-week low share price for EMvision Medical Devices Ltd. (EMV:ASX)? is AU$1.63.

What is the dividend yield for EMvision Medical Devices Ltd. (EMV:ASX)?

EMvision Medical Devices Ltd. (EMV:ASX) does not pay a dividend.

What was EMvision Medical Devices Ltd. (EMV:ASX) last dividend payment?

EMvision Medical Devices Ltd. (EMV:ASX) does not pay a dividend.

What is the franking level for EMvision Medical Devices Ltd. (EMV:ASX)?

EMvision Medical Devices Ltd. (EMV:ASX) does not offer franking credits.

In which sector is EMvision Medical Devices Ltd. (EMV:ASX) classified?

EMvision Medical Devices Ltd. (EMV:ASX) is classified in the Healthcare.

The current P/E ratio for EMvision Medical Devices Ltd. (EMV:ASX) is .